Pharma stocks are witnessing a strong rally today, attracting investor interest. Top experts Dharmesh Kant, Head of Equity Research at Chola Securities, and Vaishali Parekh, VP of Technical Research & Analysis at Prabhudas Lilladher, weigh in on the best investment opportunities. Vaishali Parekh ighlights continued positive momentum in stocks like Sun Pharma and Biocon, while also recommending cash segment stocks such as Piramal Pharma and Natco Pharma, which are showing renewed strength. Dharmesh Kant advises sticking to large-cap pharma players, with Lupin standing out for its robust quarterly performance and historical resilience. He notes that while uncertainties surrounding U.S. policy changes may cause some caution, these stocks provide a margin of safety at current levels. Tune in to explore expert insights on the top pharma stocks to invest in during this rally.